For patients with type 2 diabetes who start above an HbA1c of 8%, that level of reduction can translate to a clinically significant lower risk of microvascular complications over time
Safety concerns included uncharacterized immunogenicity risks, inadequate impurity and endotoxin testing in available raw material, the unresolved free-base versus acetate salt form distinction, and, for BPC-157 specifically, an angiogenesis mechanism that raises theoretical concerns for patients with undiagnosed tumors
Seek prompt evaluation if neck pain persists beyond a few days or occurs with swallowing difficulties, voice changes, or fever
Long-term clinical trials are crucial to assess the safety and efficacy of antiangiogenic therapies in different patient populations and disease stages
GHK-Cu acts as a physiological copper carrier in preclinical models, delivering copper into cells in a form that supports these enzymatic processes
The dosing schedule looks complicated